東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Statistical methods in biomarker and...

Fang, Liang.

FindBook

Google Book

Amazon

博客來

Statistical methods in biomarker and early clinical development

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Statistical methods in biomarker and early clinical development/ edited by Liang Fang, Cheng Su.
其他作者:	Fang, Liang.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	xii, 348 p. :ill., digital ;24 cm.
內容註:	Predictive Subgroup/Biomarker Identification and Machine Learning Methods -- Characterize and Dichotomize a Continuous Biomarker -- Surrogate Biomarkers -- Innovative Designs for Biomarker Guided Trials -- Statistical Considerations in the Development of Companion Diagnostic Device -- Biomarker Assay Development, Qualification and Validation -- Validation of Genomic Based Assay -- Clinical Application of Molecular Features in Therapeutic Selection and Drug Development -- Big data, real-world data, and machine learning -- Design and Analysis of Clinical Pharmacology Studies -- Statistical Considerations in Proof of Concept Studies -- Safety in Early Phase Studies -- Statistical Evaluation of QT/QTc Interval Prolongation -- Phase II Dose Finding -- Pharmacometrics.
Contained By:	Springer eBooks
標題:	Biochemical markers - Statistical methods. -
電子資源:	https://doi.org/10.1007/978-3-030-31503-0
ISBN:	9783030315030

Statistical methods in biomarker and early clinical development
Statistical methods in biomarker and early clinical development[electronic resource] /edited by Liang Fang, Cheng Su. - Cham :Springer International Publishing :2019. - xii, 348 p. :ill., digital ;24 cm.

Predictive Subgroup/Biomarker Identification and Machine Learning Methods -- Characterize and Dichotomize a Continuous Biomarker -- Surrogate Biomarkers -- Innovative Designs for Biomarker Guided Trials -- Statistical Considerations in the Development of Companion Diagnostic Device -- Biomarker Assay Development, Qualification and Validation -- Validation of Genomic Based Assay -- Clinical Application of Molecular Features in Therapeutic Selection and Drug Development -- Big data, real-world data, and machine learning -- Design and Analysis of Clinical Pharmacology Studies -- Statistical Considerations in Proof of Concept Studies -- Safety in Early Phase Studies -- Statistical Evaluation of QT/QTc Interval Prolongation -- Phase II Dose Finding -- Pharmacometrics.

This contributed volume offers a much-needed overview of the statistical methods in early clinical drug and biomarker development. Chapters are written by expert statisticians with extensive experience in the pharmaceutical industry and regulatory agencies. Because of this, the data presented is often accompanied by real world case studies, which will help make examples more tangible for readers. The many applications of statistics in drug development are covered in detail, making this volume a must-have reference. Biomarker development and early clinical development are the two critical areas on which the book focuses. By having the two sections of the book dedicated to each of these topics, readers will have a more complete understanding of how applying statistical methods to early drug development can help identify the right drug for the right patient at the right dose. Also presented are exciting applications of machine learning and statistical modeling, along with innovative methods and state-of-the-art advances, making this a timely and practical resource. This volume is ideal for statisticians, researchers, and professionals interested in pharmaceutical research and development. Readers should be familiar with the fundamentals of statistics and clinical trials.

ISBN: 9783030315030

Standard No.: 10.1007/978-3-030-31503-0doiSubjects--Topical Terms:

3454459
Biochemical markers
--Statistical methods.

LC Class. No.: R853.B54 / S73 2019

Dewey Class. No.: 610.28

Statistical methods in biomarker and early clinical development
LDR:03082nmm a2200337 a 4500 001 2219309
003 DE-He213
005 20191226130921.0
006 m d
007 cr nn 008maaau
008 201126s2019 gw s 0 eng d
020 $a 9783030315030 $q (electronic bk.)
020 $a 9783030315023 $q (paper)
024 7 $a 10.1007/978-3-030-31503-0 $2 doi
035 $a 978-3-030-31503-0
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.B54 $b S73 2019
072 7 $a PBT $2 bicssc
072 7 $a MED090000 $2 bisacsh
072 7 $a PBT $2 thema
072 7 $a MBNS $2 thema
082 0 4 $a 610.28 $2 23
090 $a R853.B54 $b S797 2019
245 0 0 $a Statistical methods in biomarker and early clinical development $h [electronic resource] / $c edited by Liang Fang, Cheng Su.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xii, 348 p. : $b ill., digital ; $c 24 cm.
505 0 $a Predictive Subgroup/Biomarker Identification and Machine Learning Methods -- Characterize and Dichotomize a Continuous Biomarker -- Surrogate Biomarkers -- Innovative Designs for Biomarker Guided Trials -- Statistical Considerations in the Development of Companion Diagnostic Device -- Biomarker Assay Development, Qualification and Validation -- Validation of Genomic Based Assay -- Clinical Application of Molecular Features in Therapeutic Selection and Drug Development -- Big data, real-world data, and machine learning -- Design and Analysis of Clinical Pharmacology Studies -- Statistical Considerations in Proof of Concept Studies -- Safety in Early Phase Studies -- Statistical Evaluation of QT/QTc Interval Prolongation -- Phase II Dose Finding -- Pharmacometrics.
520 $a This contributed volume offers a much-needed overview of the statistical methods in early clinical drug and biomarker development. Chapters are written by expert statisticians with extensive experience in the pharmaceutical industry and regulatory agencies. Because of this, the data presented is often accompanied by real world case studies, which will help make examples more tangible for readers. The many applications of statistics in drug development are covered in detail, making this volume a must-have reference. Biomarker development and early clinical development are the two critical areas on which the book focuses. By having the two sections of the book dedicated to each of these topics, readers will have a more complete understanding of how applying statistical methods to early drug development can help identify the right drug for the right patient at the right dose. Also presented are exciting applications of machine learning and statistical modeling, along with innovative methods and state-of-the-art advances, making this a timely and practical resource. This volume is ideal for statisticians, researchers, and professionals interested in pharmaceutical research and development. Readers should be familiar with the fundamentals of statistics and clinical trials.
650 0 $a Biochemical markers $x Statistical methods. $3 3454459
650 1 4 $a Statistics for Life Sciences, Medicine, Health Sciences. $3 891086
650 2 4 $a Physiological, Cellular and Medical Topics. $3 891099
650 2 4 $a Biostatistics. $3 1002712
700 1 $a Fang, Liang. $3 1292344
700 1 $a Su, Cheng. $3 3454458
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-31503-0
950 $a Mathematics and Statistics (Springer-11649)